Advanced search
Publication Cover
Journal of Experimental Pharmacology Volume 13, 2021 - Issue
Submit an article Journal homepage
234
Views
11
CrossRef citations to date
0
Altmetric
Review

New Avenues for Phosphodiesterase Inhibitors in Asthma

Maria Gabriella Matera1 Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, Naples, ItalyView further author information
,
Josuel Ora2 Respiratory Diseases Unit, “Tor Vergata” University Hospital, Rome, ItalyORCID Iconhttps://orcid.org/0000-0001-9877-7851View further author information
ORCID Icon,
Francesco Cavalli2 Respiratory Diseases Unit, “Tor Vergata” University Hospital, Rome, ItalyView further author information
,
Paola Rogliani2 Respiratory Diseases Unit, “Tor Vergata” University Hospital, Rome, Italy;3 Department of Experimental Medicine, University of Rome “Tor Vergata”, Rome, ItalyORCID Iconhttps://orcid.org/0000-0001-7801-5040View further author information
ORCID Icon &
Mario Cazzola3 Department of Experimental Medicine, University of Rome “Tor Vergata”, Rome, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4895-9707View further author information
ORCID Icon
Pages 291-302 | Published online: 15 Mar 2021

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Mario Cazzola, Nicola A Hanania, Clive P Page & Maria Gabriella Matera. (2023) Novel Anti-Inflammatory Approaches to COPD. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1333-1352.
Read now
Mario Cazzola, Paola Rogliani, Silvio Naviglio, Luigino Calzetta & Maria Gabriella Matera. (2022) An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma. Expert Opinion on Pharmacotherapy 23:10, pages 1205-1216.
Read now
Maria Gabriella Matera, Luigino Calzetta, Rosa Annibale, Francesco Russo & Mario Cazzola. (2021) Classes of drugs that target the cellular components of inflammation under clinical development for COPD. Expert Review of Clinical Pharmacology 14:8, pages 1015-1027.
Read now

Articles from other publishers (8)

Katarzyna Wójcik-Pszczoła, Krzysztof Pociecha, Grażyna Chłoń-Rzepa, Monika Zadrożna, Barbara Nowak, Hanna Plutecka, Paulina Koczurkiewicz-Adamczyk, Katarzyna Przejczowska-Pomierny, Elżbieta Pękala, Reinoud Gosens & Elżbieta Wyska. (2023) Inhaled pan-phosphodiesterase inhibitors ameliorate ovalbumin-induced airway inflammation and remodeling in murine model of allergic asthma. International Immunopharmacology 119, pages 110264.
Crossref
Jia-Xi Huang, Bo-Lin Zhu, Jiang-Ping Xu & Zhong-Zhen Zhou. (2023) Advances in the development of phosphodiesterase 7 inhibitors. European Journal of Medicinal Chemistry 250, pages 115194.
Crossref
Mastiyage R Goonathilake, Sara Waqar, Sheeba George, Wilford Jean-Baptiste, Amina Yusuf Ali, Bithaiah Inyang, Feeba Sam Koshy, Kitty George, Prakar Poudel, Roopa Chalasani & Lubna Mohammed. (2022) Can Phosphodiesterase 4 Inhibitor Therapy Be Used in Respiratory Diseases Other Than Chronic Obstructive Pulmonary Disease?. Cureus.
Crossref
Katarzyna Wójcik-Pszczoła, Grażyna Chłoń-Rzepa, Agnieszka Jankowska, Bruno Ferreira, Paulina Koczurkiewicz-Adamczyk, Elżbieta Pękala, Elżbieta Wyska, Krzysztof Pociecha & Reinoud Gosens. (2022) Pan-Phosphodiesterase Inhibitors Attenuate TGF-β-Induced Pro-Fibrotic Phenotype in Alveolar Epithelial Type II Cells by Downregulating Smad-2 Phosphorylation. Pharmaceuticals 15:4, pages 423.
Crossref
Mario Cazzola, Paola Rogliani & Maria Gabriella Matera. (2022) The Future of Bronchodilators in COPD and Asthma. Archivos de Bronconeumología 58:2, pages 107-108.
Crossref
Mario Cazzola, Clive Page & Maria Gabriella Matera. (2022) Ensifentrine: A First-in-class Bifunctional Drug for the Treatment of Chronic Obstructive Pulmonary Disease. US Respiratory & Pulmonary Diseases 7:2, pages 48.
Crossref
Mario Cazzola, Josuel Ora, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2022) The future of inhalation therapy in chronic obstructive pulmonary disease. Current Research in Pharmacology and Drug Discovery 3, pages 100092.
Crossref
Mario Cazzola & Maria Gabriella Matera. (2021) Is it time to look beyond bronchodilators and corticosteroids in treating COPD?. Future Drug Discovery 3:2.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.